Deog Joong Kim

This inventor holds 15 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Nanoparticle Drug Delivery. Top assignees: Rexahn Pharmaceuticals, Inc., The Mclean Hospital Corporation, The Ohio State University. Active years: 2012-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deog Joong Kim. Retrieved from https://idiyas.com/inventor/deog-joong-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 4)

% Patents Active = 40.0

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 14)

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 21(Granted Patents)

Company Filing History:

13 out of 19

Rexahn Pharmaceuticals, Inc.

patents

1 out of 125

The Mclean Hospital Corporation

patents

1 out of 1,584

The Ohio State University

patents

4. 1 out of 2,029

University System of Maryland

patents

where one patent can have more than one assignee

Years Active: 2012-2020

Loading Chart...

Areas of Expertise:

Nanoparticle Compositions

Antisense Oligonucleotides

Piperazine Compounds

Anticancer Drugs

Fluorocyclopentenylcytosine

Quinoxalinyl-piperazinamide

Polymeric Systems

Parkinson's Disease

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10570101 - Quinoxalinyl-piperazinamide methods of use (2020-02-25),

2. 10307490 - Lipid nanoparticle compositions for antisense oligonucleotides delivery (2019-06-04),

3. 10278971 - Fluorocyclopentenylcytosine methods of use (2019-05-07),

4. 10052321 - Nanoparticulate compositions and formulations of piperazine compounds (2018-08-21),

5. 9969698 - Quinoxalinyl-piperazinamide methods of use (2018-05-15),

6. 9920016 - Process for the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one (2018-03-20),

7. 9782410 - Fluorocyclopentenylcytosine methods of use (2017-10-10),

8. 9744167 - Nanoparticulate compositions and formulations of piperazine compounds (2017-08-29),

9. 9713615 - Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds (2017-07-25),

10. 9533958 - Process or the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-Enyl)-1H-pyrimidin-2-one (2017-01-03),

11. 9434610 - HPMA—docetaxel conjugates and uses therefore (2016-09-06),

12. 9193707 - Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds (2015-11-24),

13. 9150520 - Process for the preparation of 4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one (2015-10-06),

14. 8846110 - Polymeric systems for the delivery of anticancer drugs (2014-09-30),

15. 8114892 - Methods and compositions for the treatment of Parkinson's Disease (2012-02-14),

Title: The Innovative Contributions of Deog Joong Kim

Introduction

Deog Joong Kim is a prominent inventor based in Rockville, MD, with a remarkable portfolio of 15 patents. His work primarily focuses on advancements in pharmaceutical formulations and delivery systems, showcasing his commitment to improving healthcare through innovative solutions.

Latest Patents

Among his latest patents, Kim has developed methods involving Quinoxalinyl-piperazinamide, which provides methods using and kits comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof. Additionally, he has created lipid nanoparticle compositions for the delivery of antisense oligonucleotides. This composition includes a macromolecule conjugated to a polymer and a targeting agent, which can include a therapeutic agent such as an antisense oligonucleotide (ASO). Notably, some ASOs are targeted to modulate the expression of Akt-1 or HIF-1, demonstrating the potential for treating various cancers through these innovative lipid nanoparticle formulations.

Career Highlights

Throughout his career, Deog Joong Kim has made significant contributions while working with notable organizations such as Rexahn Pharmaceuticals, Inc. and The Ohio State University. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Kim has collaborated with esteemed colleagues, including Young Bok Lee and Reza Mazhari, further enhancing the impact of his work in the field of pharmaceuticals.

Conclusion

Deog Joong Kim's innovative contributions to pharmaceutical formulations and delivery systems highlight his dedication to advancing healthcare solutions. His extensive patent portfolio and collaborations with leading professionals underscore his significant role in the field of invention.

Profile summary based on public USPTO records.